Interferon (IFN)-α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-α in vivo

Journal of Experimental Medicine

Volumn 186, Issue 9, 1997, Pages 1495-1502

  Sharara, Ala I ^a   Perkins, Douglas J ^a   Misukonis, Mary A ^a   Chan, Stanley U ^a   Dominitz, Jason A ^a   Weinberg, J Brice ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 1; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANTIVIRAL AGENTS; ENZYME INDUCTION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER;

EID: 0030726545     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.9.1495     Document Type: Article

References (50)

1. Nathan, C., and Q.-W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
2. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
3. Nathan, C.F., and J.B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
4. Degroote, M.A., and F.C. Fang. 1995. NO inhibitions. Antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21:S162-S165.
5. Mannick, J.B. 1995. The antiviral role of nitric oxide. Res. Immunol. 146:693-697.
6. Weinberg, J.B., M.A. Misukonis, P.J. Shami, S.N. Mason, D.L. Sauls, W.A. Dittman, E.R. Wood, G.K. Smith, B. McDonald, K.E. Bachus, et al. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS). Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 86:1184-1195.
7. St. Clair, E.W., W.E. Wilkinson, T. Lang, L. Sanders, M.A. Misukonis, G.S. Gilkeson, D.S. Pisetsky, D.L. Granger, and J.B. Weinberg. 1996. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med. 184:1173-1178.
8. Albina, J.E. 1995. On the expression of nitric oxide synthase by human macrophages - why no NO [review]. J. Leukocyte Biol. 58:643-649.
9. Anstey, N.M., J.B. Weinberg, M. Hassanali, E.D. Mwaikambo, D. Manyenga, M.A. Misukonis, D.R. Arnelle, D. Hollis, M.I. McDonald, and D.L. Granger. 1996. Nitric oxide in Tanzanian children with malaria. Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184:557-567.
10. Sakurai, H., H. Kohsaka, M.F. Liu, H. Higashiyama, Y. Hirata, K. Kanno, I. Saito, and N. Miyasaka. 1995. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96:2357-2363.
11. Nicholson, S., M.D.G. Bonecinialmeida, L.E. Silva, Jr., C. Nathan, Q.W. Xie, R. Mumford, J.R. Weidner, J. Calaycay, J. Geng, N. Boechat, et al. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302.
12. Ding, A.H., C.F. Nathan, and D.J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence tor independent production. J Immunol. 141:2407-2412.
13. Zhou, A.Q., Z.F. Chen, J.A. Rummage, H. Jiang, M. Kolosov, I. Kolosova, C.A. Stewart, and R.W. Leu. 1995. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J. Interferon Cytokine Res. 15: 897-904.
14. Sherman, P.A., V.E. Laubach, B.R. Reep, and E.R. Wood. 1993. Purification and cDNA sequence of an inducible nitric-oxide synthase from a human tumor cell line. Biochemistry. 32:11600-11605.
15. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
16. Vilcek, J., and G.C. Sen. 1996. Interferons and other cytokines. In Virology. 3rd ed. Vol. 1. B.N. Fields, D.M. Knipe and P.M. Howley, editors. Lippincott-Raven, Philadelphia. 375-399.
17. Tsai, J.F., J.E. Jeng, W.Y. Chang, M.S. Ho, Z.Y. Lin, and J.H. Tsai. 1995. Circulating immune complexes in chronic hepatitis C. J. Med. Virol. 46:12-17.
18. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6: 3051-3064.
19. Mulligan, M.S., S. Moncada, and P.A. Ward. 1992. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br. J. Pharmacol. 107:1159-1162.
20. Hibbs, J.B., Jr., R.R. Taintor, Z. Vavrin, D.L. Granger, J.-C. Drapier, I.J. Amber, and J.R. Lancaster, Jr. 1990. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Nitric Oxide from L-arginine: A Bioregulatory System. S. Moncada and E.A. Higgs, editors. Elsevier Science Publishers B.V., New York. 189-223.
21. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650.
22. MacMicking, J.D., R.J. North, R. LaCourse, J.S. Mudgett, S.K. Shah, and C.F. Nathan, 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA. 94:5243-5248.
23. Croen, K.D. 1993. Evidence tor antiviral effect of nitric oxide. Inhibition of herpes simplex virus type I replication. J. Clin. Invest. 91:2446-2452.
24. Bi, Z., and C.S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
25. Karupiah, G., Q.W. Xie, R.M. Buller, C. Nathan, C. Duarte, and J.D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (Wash. DC). 261:1445-1448.
26. Karupiah, G., and N. Harris. 1995. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181:2171-2179.
27. Mannick, J.B., K. Asano, K. Izumi, E. Kieff, and J.S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79: 1137-1146.
28. Lowenstein, C.J., S.L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Laudavere, N.R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837-1843.
29. Lin, Y.-L., Y.-L. Huang, S.-H. Ma, C.-T. Yeh, S.-Y. Chiou, L.-K. Chen, and C.-L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71:5227-5235.
30. Melkova, Z., and M. Esteban. 1995. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155:5711-5718.
31. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442-448.
32. Stamler, J.S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 78:931-936.
33. Tamir, S., S. Burney, and S.R. Tannenbaum. 1996. DNA damage by nitric oxide. Chem. Res. Toxicol. 9:821-827.
34. Sharara, A.I., C.M. Hunt, and J.D. Hamilton. 1996. Hepatitis C [review]. Ann. Intern. Med. 125:658-668.
35. Hayashi, H., T. Takikawa, N. Nishimura, M. Yano, T. Isomura, and N. Sakamoto. 1994. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron [see comments]. Am. J. Gastroenterol. 89:986-988.
36. Ikura, Y., H. Morimoto, H. Johmura, M. Fukui, and M. Sakurai. 1996. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am. J. Gastroenterol. 91:1367-1373.
37. Piperno, A., M. Sampietro, R. Dalba, L. Roffi, S. Fargion, S. Parma, C. Nicoli, N. Corbetta, M. Pozzi, V. Arosio, et al. 1996. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 16:248-254.
38. Weiss, G., C. Werner-Felmayer, E.R. Werner, K. Gruenewals, H. Wachter, and M.W. Hentze. 1994. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180:969-976.
39. Drapier, J.C., and J.B. Hibbs, Jr. 1986. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. 78:790-797.
40. Vial, T., and J. Descotes. 1995. Immune-mediated side-effects of cytokines in humans. Toxicology. 105:31-57.
41. Wandl, U.B., M. Nagel-Hiemke, D. May, E. Kreuzfelder, O. Kloke, M. Kranzhoff, S. Seeber, and N. Niederle. 1992. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin. Immunol. Immunopathol. 65:70-74.
42. Ronnblom, L.E., G.V. Alm, and K. Oberg. 1991. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treamient. Acta. Oncol. 30:537-540.
43. Nadir, F., S. Fagiuoli, H.I. Wright, A. Nadir, L. Hopp, J. Gavaler, and D.H. Van Thiel. 1994. Rheumatoid arthritis: a complication of interferon therapy. Journal of the Oklahoma State Medical Association. 87:228-230.
44. Farrell, A.J., D.R. Blake, R.M. Palmer, and S. Moncada. 1992. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1219-1222.
45. McInnes, L.B., B.P. Leung, M. Field, X.Q. Wei, F.P. Huang, R.P. Sturrock, A. Kinninmonth, J. Weidner, R. Mumford, and F.Y. Liew. 1996. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184:1519-1524.
46. Ueki, Y., S. Miyake, Y. Tominaga, and K. Eguchi. 1991. Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23:230-236.
47. Amaro, M.J., J. Bartolome, M. Pardo, T. Cotonat, A. Lopez-farre, and V. Carreno. 1997. Decreased nitric oxide production in chronic viral hepatitis B and C. J. Med. Virol. 51:326-331.
48. Nussler, A.K., M. Di Silvio, T.R. Billiar, R.A. Hoffman, D.A. Geller, R. Selby, J. Madariaga, and R.L. Simmons. 1992. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261-264.
49. Kane, J.M., III, L.L. Shears II, C. Hierholzer, S. Ambs, T.R. Billiar, and M.C. Posner. 1997. Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J. Surg. Res. 69: 321-324.
50. Saavedra, J.E., T.R. Billiar, D.L. Williams, Y.M. Kim, S.C. Watkins, and L.K. Keefer. 1997. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J. Med. Chem. 40:1947-1954.